Literature DB >> 8708681

Incidence of intracranial tumours in the Lothian region of Scotland, 1989-90.

C E Counsell1, D A Collie, R Grant.   

Abstract

OBJECTIVE: To determine the incidence of primary and secondary intracranial tumours in the Lothian region of south east Scotland.
METHODS: A population based study was performed. Patients from Lothian with incident intracranial tumours diagnosed in 1989 and 1990 (by CT or histology) were identified retrospectively using multiple sources. Differences in incidence by tumour type, age, sex, and socioeconomic status were examined.
RESULTS: Four hundred and forty two patients with incident intracranial tumours were identified (228 primary tumours and 214 secondary tumours). The crude yearly incidences of primary and secondary tumours were 15.3 and 14.3 per 100,000 respectively. The commonest primary tumours were neuroepithelial tumours (53.5%), meningeal tumours (19.5%), and sellar tumours (16.5%). About 50% of patients with secondary tumours had an underlying lung cancer. The incidence of primary and secondary tumours increased markedly with age. Meningeal tumours were more common in women, and neuroepithelial tumours were more common in those who lived in more affluent areas.
CONCLUSIONS: The incidence rates of primary and secondary intracranial tumours in Lothian were more than twice those previously reported in the United Kingdom. Intracranial tumours are a significant cause of morbidity and mortality in the United Kingdom, and further research into their aetiology and treatment is urgently required.

Entities:  

Mesh:

Year:  1996        PMID: 8708681      PMCID: PMC1073987          DOI: 10.1136/jnnp.61.2.143

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  23 in total

1.  Neurological disease in an English city.

Authors:  M Brewis; D C Poskanzer; C Rolland; H Miller
Journal:  Acta Neurol Scand       Date:  1966       Impact factor: 3.209

2.  Epidemiologic study of primary intracranial neoplasms.

Authors:  J F Annegers; B S Schoenberg; H Okazaki; L T Kurland
Journal:  Arch Neurol       Date:  1981-04

3.  An epidemiological survey of primary tumours of the brain and spinal cord in South East Wales.

Authors:  G C Cole; P R Wilkins; R R West
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

4.  Brain metastases in small cell carcinoma of the lung.

Authors:  R E Burgess; V F Burgess; N J Dibella
Journal:  JAMA       Date:  1979-11-09       Impact factor: 56.272

5.  What follows diagnosis by computed tomography of solitary brain tumour? Audit of one year's experience in South East Scotland.

Authors:  N V Todd; T McDonagh; J D Miller
Journal:  Lancet       Date:  1987-03-14       Impact factor: 79.321

6.  Epidemiology of central nervous system neoplasms. A regional survey in Central Finland.

Authors:  R Fogelholm; T Uutela; K Murros
Journal:  Acta Neurol Scand       Date:  1984-03       Impact factor: 3.209

Review 7.  The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today.

Authors:  R Doll; R Peto
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

8.  Incidental meningiomas in autopsy study.

Authors:  S Nakasu; A Hirano; T Shimura; J F Llena
Journal:  Surg Neurol       Date:  1987-04

9.  The resolution of discrepancies in the reported incidence of primary brain tumors.

Authors:  B S Schoenberg; B W Christine; J P Whisnant
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

10.  The incidence of cerebral glioma in the working population: a forgotten cancer?

Authors:  R Grant; D Collie; C Counsell
Journal:  Br J Cancer       Date:  1996-01       Impact factor: 7.640

View more
  28 in total

1.  Treating high grade gliomas in the elderly: the end of ageism?

Authors:  Nitin Mukerji; Desiderio Rodrigues; Gill Hendry; Peter R C Dunlop; Fiona Warburton; Philip J Kane
Journal:  J Neurooncol       Date:  2007-11-17       Impact factor: 4.130

2.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

3.  Incidence of brain tumours in two English counties: a population based study.

Authors:  L H Pobereskin; J B Chadduck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-10       Impact factor: 10.154

Review 4.  The worldwide incidence and prevalence of primary brain tumors: a systematic review and meta-analysis.

Authors:  Paula de Robles; Kirsten M Fiest; Alexandra D Frolkis; Tamara Pringsheim; Callie Atta; Christine St Germaine-Smith; Lundy Day; Darren Lam; Nathalie Jette
Journal:  Neuro Oncol       Date:  2014-10-13       Impact factor: 12.300

Review 5.  Diagnosis and treatment in neuro-oncology: an oncological perspective.

Authors:  J H Rees
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

6.  Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.

Authors:  Suresh K Balasubramanian; Mayur Sharma; Vyshak A Venur; Philipp Schmitt; Rupesh Kotecha; Samuel T Chao; John H Suh; Lilyana Angelov; Alireza M Mohammadi; Michael A Vogelbaum; Gene H Barnett; Xuefei Jia; Nathan A Pennell; Manmeet S Ahluwalia
Journal:  Neuro Oncol       Date:  2020-02-20       Impact factor: 12.300

7.  Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide.

Authors:  J Sherriff; J Tamangani; L Senthil; G Cruickshank; D Spooner; B Jones; C Brookes; P Sanghera
Journal:  Br J Radiol       Date:  2013-02       Impact factor: 3.039

8.  Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.

Authors:  Courtney Kromer; Jordan Xu; Quinn T Ostrom; Haley Gittleman; Carol Kruchko; Raymond Sawaya; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-05-31       Impact factor: 4.130

9.  Predictors and survival in patients with melanoma brain metastases.

Authors:  Ugo Bottoni; Rita Clerico; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Stefano Calvieri
Journal:  Med Oncol       Date:  2013-02-02       Impact factor: 3.064

10.  Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data.

Authors:  Priscila H Goncalves; Stephanie L Peterson; Fawn D Vigneau; Ronald D Shore; William O Quarshie; Khairul Islam; Ann G Schwartz; Antoinette J Wozniak; Shirish M Gadgeel
Journal:  Cancer       Date:  2016-04-08       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.